Novel L-tryptophan-functionalized zirconium dioxide nanoparticles catalysed one-pot and solvent-free synthesis of 2 H-indazolo [2, 1-b] phthalazine-triones.

Ali Kareem Abbas, Javad Safaei-Ghomi, Samira Moein-Najafabadi

Abstract read

In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ali Kareem AbbasCollege of Applied Medical Sciences, University of Kerbala, Kerbala, Iraq.

Javad Safaei-GhomiDepartment of Organic Chemistry, Faculty of Chemistry, University of Kashan, P.O. Box 87317-51167, Kashan, I. R. of Iran. safaei@kashanu.ac.ir.

Samira Moein-NajafabadiDepartment of Organic Chemistry, Faculty of Chemistry, University of Kashan, P.O. Box 87317-51167, Kashan, I. R. of Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Zirconia nanoparticles modified with L-tryptophan (ZrO₂@L-Try) demonstrate increased biocompatibility and catalytic activity by capitalizing on the bioactive properties of L-tryptophan, a crucial amino acid known for its role in protein synthesis and neurochemical functions. Successful integration of L-tryptophan onto the ZrO

Identifiers

PMID40653526

DOI10.1038/s41598-025-11227-z

PMCPMC12256634

What OpenQuestion holds

Textmetadata

LicenceCC BY-NC-ND

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.